Concepedia

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

Cédric Draulans, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Jochem van der Voort van Zyp, Hans de Boer, V. Groen, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch,

Radiotherapy and Oncology · 2020 · 177 citations · 36 references

DOIFull text

Open access

Concepts

References

36

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

, , +16

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 3.3K citations · Full text

, , +17

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke et al. · European Urology · 2015 · 2.9K citations

, , +16

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David P. Dearnaley, Isabel Syndikus, Helen Mossop et al. · The Lancet Oncology · 2016 · 1.3K citations · Full text

, , +17

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

, , +16